Mounjaro

Eli Lilly Introduces Mounjaro Single-Dose Vial for Diabetes and Obesity

Mounjaro® is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.